Journal of Infection

Papers
(The H4-Index of Journal of Infection is 83. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The pathogenesis and treatment of the `Cytokine Storm' in COVID-191926
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis1483
Co-infections in people with COVID-19: a systematic review and meta-analysis1015
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients946
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up780
Characteristics of COVID-19 infection in Beijing725
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19708
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis673
Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China652
The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2548
Clinical progression of patients with COVID-19 in Shanghai, China544
SARS-CoV-2 detection, viral load and infectivity over the course of an infection536
Saliva is a reliable tool to detect SARS-CoV-2506
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19497
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study417
COVID-19 spike-host cell receptor GRP78 binding site prediction358
Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries352
Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2342
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study337
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact318
Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19281
Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children264
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation261
Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients242
Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patient237
The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis224
Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China224
Withdrawn: Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy214
Emergence of a new SARS-CoV-2 variant in the UK211
CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China199
Severe air pollution links to higher mortality in COVID-19 patients: The “double-hit” hypothesis.198
Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva197
Current epidemiological and clinical features of COVID-19; a global perspective from China191
Coronavirus 2019-nCoV: A brief perspective from the front line190
Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy176
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?176
Profile of specific antibodies to SARS-CoV-2: The first report174
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19168
SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes167
Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis166
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study165
High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients164
Environmental contamination of SARS-CoV-2 in healthcare premises162
How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review143
Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies141
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients138
Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19136
Interleukin-6 as prognosticator in patients with COVID-19135
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients135
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study134
Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2132
First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics129
The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination128
Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission126
Household transmission of SARS-CoV-2125
Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure125
Viral dynamics of SARS-CoV-2 in saliva from infected patients123
Risk factors associated with disease severity and length of hospital stay in COVID-19 patients120
Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis120
Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK116
The duration of infectiousness of individuals infected with SARS-CoV-2110
Regional air pollution persistence links to COVID-19 infection zoning110
Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis108
Household transmission of COVID-19-a systematic review and meta-analysis107
A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis107
Transmission of monkeypox virus through sexual contact – A novel route of infection105
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients104
Breast milk microbiota: A review of the factors that influence composition104
Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects103
SARS-CoV-2 (COVID-19) superspreader events103
Emergence of a novel coronavirus causing respiratory illness from Wuhan, China102
Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19100
Serum ferritin as an independent risk factor for severity in COVID-19 patients98
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review98
Post-COVID-19 functional status six-months after hospitalization91
Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers91
Excess mortality due to COVID-19 in Germany91
Effects of age and sex on recovery from COVID-19: Analysis of 5769 Israeli patients91
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis91
Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden – a systematic review87
Clinical features and outcomes of pregnant women suspected of coronavirus disease 201985
Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection85
Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load84
0.049216032028198